RxPros review

RxPros presents an accessible online route to compounded semaglutide and tirzepatide with clinician review and delivery. Its strongest practical feature is the stated inclusion of the consultation, medication and shipping rather than a separate advertised membership. The largest reservation is the financial agreement. The lowest homepage prices are labeled elsewhere on the same page as annual equivalents, while additional promotional sections display different amounts. More importantly, the refund agreement describes a minimum three-month GLP-1 commitment and payment liability if the patient leaves early. That substantially narrows a casual reading of the homepage’s cancellation promise. We would compare RxPros using the complete amount due, commitment, renewal schedule and prescription-processing cutoff in a written offer. A low monthly headline is insufficient to establish that the program is inexpensive for someone who may need to stop after the first supply.

The website and terms identify RxPros LLC as the platform business. It connects patients with medical providers and pharmacy services; the published material does not establish one named dispensing pharmacy or a particular medical group guaranteed for every order. References to board-certified doctors, regulated pharmacies and third-party testing are the company’s statements, not independent credential or laboratory verification by Aminoscope. The site describes compounded preparations containing semaglutide or tirzepatide with additives such as vitamins or glycine. These details make it especially important to obtain the actual prescription composition rather than assume a plain branded product is being delivered. The business provides phone and email support and a patient sign-in route. Its legal page includes several state-specific notices, but a collection of consumer notices does not establish a complete current state coverage list. Confirm eligibility for the selected medication and delivery address before supplying payment information.

The advertised process starts with a health questionnaire and an online consultation with a licensed provider, followed by pharmacy preparation if treatment is prescribed. Clinical approval is discretionary. The website’s rapid approval and delivery statements should be understood as advertised timelines, not a promise that an individual prescription will be issued within a fixed period. Continuing support and communication through the patient portal are described as part of care. Before joining, ask who will answer medical questions, which follow-up assessments precede refills and how a treatment change is handled when several months have already been dispensed. Those questions are material because the payment agreement says the minimum term reflects three months of medication supplied upfront. A dose adjustment or unexpected intolerance can therefore create a mismatch between unused medication and an outstanding installment balance. Ask the clinician and dispensing pharmacy how they manage that possibility before selecting a longer purchase. The billing dashboard and clinical portal also serve different purposes: asking a clinician about stopping medication may not cancel a payment agreement. Request confirmation from the billing team as well as a medical plan from the prescriber. Save the selected offer and agreement, since the several public prices do not reliably identify which commitment a particular patient accepted.

The comparison table labels compounded semaglutide from $99.99 per month and tirzepatide from $144.97 per month as paid annually. Other homepage panels show $149/$249 and $134.99/$224.99 promotional pairs, accompanied by introductory or quarterly-savings wording. These are not interchangeable recurring monthly quotes. We do not assign a numeric monthly floor from those panels. Request the exact upfront annual or quarterly total, any installments, the price after discounts and the standard price used to calculate early-exit liability. The payment agreement says subscriptions renew automatically and GLP-1 programs require at least three months, with longer selected plans also binding. Leaving early can trigger the retail price of the remaining commitment. Cancellation before a medical consultation may receive a refund less a $99 administrative fee if approved; after consultation and prescription issuance, orders are described as final even if not shipped. Denial by the provider is described as fully refundable. The same page mentions a $150 prescription-modification fee after pharmacy transmission. Treat these as the company’s contractual policies, rather than accepting its generalized legal explanations as an independent statement of consumer law.

RxPros describes its injections as compounded and says they are not substitutes for FDA-approved finished products. Other promotional wording refers to approved pharmacies and presents large weight-loss percentages beside the compounded offers. A pharmacy’s regulatory status does not confer FDA approval on the compounded preparation, and results from a branded-drug trial cannot establish outcomes for an additive-containing compounded vial. Vitamins or glycine also should not be assumed to reduce side effects or improve weight loss without evidence for the specific formulation. Ask why the prescriber recommends compounding for your needs, which pharmacy will prepare it and how the concentration is communicated in both milligrams and syringe units. For multimonth supply, obtain written storage conditions and beyond-use dates. The returns page contains broad temperature-stability claims, but the actual pharmacy’s label and individualized handling instructions should govern a shipment concern. Report a problem promptly; the published replacement process uses a seven-day reporting window for several delivery or product issues.